Mon, 15 Oct 2018 08:30:52 GMT
Innovent Biologics seeks to attract $422M in HK IPO
China's biotech company Innovent Biologics is seeking to attract $422M in its initial public offering in Hong Kong that could potentially be the largest biotech IPO in this year's financial hub.